Coronavirus disease 2019 outcomes in a population-based cohort of people with HIV and a matched cohort of people without HIV during Omicron variant waves

We found that rates of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing and reverse transcriptase (RT)-PCR-confirmed infection were approximately 50% higher in a population-based cohort of people with HIV compared with a matched cohort of people without HIV during the Omicron era (2 January 2022 to 31 March 2023) in Ontario, Canada, after controlling for age, sex, residential census tract, and country of birth. Rates of coronavirus disease 2019 (COVID-19)-related hospitalization and/or death were more than double. Differences persisted independent of vaccination, healthcare access, and COVID-19 diagnosis.

View Source

Information

Citation

Chambers C, Cooper CL, Kroch AE, Buchan SA, Kendall CE, Kwong JC, Moideddin R, Nguyen L, Arbess G, Benoit AC, Costiniuk CT, Habanyama M, Janjua NZ, Langlois MA, McCullagh J, Mbuagbaw L, Moqueet N, Nambiar D, Rueda S, Samji H, Tran V, Walmsley S, Anis A, Burchell AN; COVAXHIV Study Team. AIDS. 2024 Aug; 38(10):1597-1600.

View Source

Contributing ICES Scientists

Research Programs

Populations & Public Health

Associated Topics

Associated Sites

ICES Central

Discover More

Journal Article

06/06/2025

Prematurity at birth and risk of self-injury, overdose or death in adolescence and early adulthood: a population-based cohort study

Ray JG, Pirouzmand N, Park AL, Austin PC, Vigod S, Grandi S, Berger H, Cohen E. Ann Epidemiol. 2025; S1047-2797(25):00117-6. Epub 2025 Jun 6.

Journal Article

02/06/2025

A retrospective evaluation of access equity in virtual care during the COVID-19 pandemic: a 2-year review and comparison of visits in Ontario, Canada

Mondoux S, Battaglia F, Gayowsky A, Clayton N, Langmann C, Miller P, Pardhan A, Matthews J, Drossos A, Grewal K. PLoS One. 2025; 20(6):e0323303.

Journal Article

28/05/2025

Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: a multinational self-controlled case series study

Nasreen S, Jiang Y, Lu H, Lee A, Cutland CL, Gentile A, Giglio N, Macartney K, Deng L, Liu B, Sonneveld N, Bellamy K, Clothier HJ, Sepulveda Kattan G, Naus M, Naveed Z, Janjua NZ, Nguyen L, Hviid A, Poukka E, Perälä J, Leino T, Chandra LA, Thobari JA, Park BJ, Choi NK, Jeong NY, Madhi SA, Villalobos F, Solórzano M, Bissacco CA, Carreras-Martínez JJ, Correcher-Martínez E, Urchueguía-Fornes A, Roy D, Yeomans A, Aurelius T, Morton K, Di Mauro G, Sturkenboom MC, Sejvar JJ, Top KA, Batty K, Ghebreab L, Griffin JB, Petousis-Harris H, Buttery J, Black S, Kwong JC. Vaccine. 2025 May 28;60:127291. [Epub ahead of print].

See All